Seebri (glycopyrronium bromide)

pCPA File Number: 20796

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0300-000

pCPA Engagement Letter Issued:

2013-06-01

Negotiation Process Concluded:

2013-07-29